Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
Date:5/6/2008

er Conference. The

final efficacy results confirmed previously announced interim

results showing a survival benefit in patients with recurrent SCLC

who failed prior platinum-containing first-line chemotherapy or who

progressed within six months of first-line therapy. The median

overall survival in the picoplatin Phase 2 trial was 27 weeks for

refractory and resistant small cell lung cancer patients, a

population for which there is no approved therapy in the US. The

Pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse)

trial of intravenous picoplatin in SCLC is ongoing and compares

picoplatin with best supportive care to best supportive care alone.

The published median overall survival for best supportive care is 13

weeks for the platinum refractory and resistant patient group. Our

registrational trial is currently being conducted under a Special

Protocol Assessment from the U.S. Food and Drug Administration and

is evaluating overall survival as the primary endpoint. Top-line

Phase 3 data is targeted for mid-2009.

* Colorectal Cancer: In January, we presented preliminary safety data

from our 50-patient Phase 1 dose-escalation study of picoplatin in

patients with metastatic colorectal cancer at the ASCO

Gastrointestinal Cancers Symposium. Picoplatin was shown to have

manageable toxicity in combination with 5-fluorouracil and

leucovorin. Picoplatin did not cause severe neurotoxicity (Grade 3

or higher), as is commonly seen in metastatic CRC patients treated

with oxaliplatin as part of the FOLFOX regimen. Current National

Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in

Oncology for colon cancer encourage the discontinuation of FOLFO
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
5. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
6. Onyx Pharmaceuticals Reports 2008 First Quarter Results
7. SGX Pharmaceuticals Schedules Teleconference and Webcast to Discuss First Quarter 2008 Results and Provide Pipeline Update
8. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
9. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
10. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
11. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014 Research and Markets ... of the "Technology Innovations in Smart Fabrics ... http://photos.prnewswire.com/prnh/20130307/600769 ... Fabrics" offers a detailed assessment on technological advancements ... Findings: 1. The Smart Fabrics ...
(Date:12/19/2014)... Arkansas (PRWEB) December 18, 2014 ... to locate its pilot production facility and future ... develop and produce innovative new materials that safely ... chosen not only because of its historic, strong ... leaders’ efforts to attract leading edge, technology-based companies ...
(Date:12/19/2014)... 18, 2014 Ed Bilsky, Ph.D., vice ... Center for Excellence in the Neurosciences (CEN), and professor ... been selected as a member of the prestigious Dana ... neuroscientist from Maine to receive this honor. , ... entirely by the Dana Foundation. Its mission is ...
(Date:12/19/2014)... iLab Solutions, the global leader in ... Bryant as the new Director of Institutional Implementations and ... These two new leadership positions were created to support ... that iLab continues to meet the needs of its ... iLab has been deployed at over 450 core facilities ...
Breaking Biology Technology:Technology Innovations in Smart Fabrics (Technical Insights) 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... be made using molybdenite. In an article appearing online ... EPFL,s Laboratory of Nanoscale Electronics and Structures (LANES) publishes ... over traditional silicon or graphene for use in electronics ... an important role in electronics, allowing us to make ...
... 28, 2011 Neuralstem, Inc. (Amex: CUR ... ReNeuron, Ltd. ending litigation between the parties.  The confidential ... ReNeuron in Neuralstem, Inc. v. ReNeuron, Ltd. , ... in the United States District Court for the Central ...
... available in Spanish and French . , ... From this fibrous diet consisting mainly of the tough to degrade ... value to most animals, ruminants manage to extract all they need ... now, the cow, or rather the network of organisms working unseen ...
Cached Biology Technology:New transistors: An alternative to silicon and better than graphene 2Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd. 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 2How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 3How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 4How now, inside the cow: Nearly 30,000 novel enzymes for biofuel production improvements 5
(Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... BETHESDA, Md. , Nov. 17, 2014 The ... European and U.S. regulatory agencies will speak and at least ... Quality Metrics Conference at the Omni Shoreham Hotel in ... is pleased once again to have significant support from the ... and Europe in our effort to ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... drug made to enhance memory appears to trigger a natural ... even after the drug itself has left the body, according ... Gary Lynch, along with Associate Researcher Julie Lauterborn, were among ... a class of drugs known as ampakines. Ampakines were developed ...
... benign compound contained in a widely used group of ... existing pesticides in the environment, according to a new ... Berkeley. , While the increase in toxicity was relatively ... unexpected, the researchers said. , The study's results, reported ...
... so overjoyed are they at hearing her words. What does ... your passion for spicy cuisine. Drink red wine. Enjoy coffee ... and, what the heck, eat a grapefruit, too. Gerson says ... the notion that eating these foods will make heartburn worse ...
Cached Biology News:Drug triggers body's mechanism to reverse aging effect on memory process 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 2Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 3Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 4
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
... X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C ... Cl N O 6 ,M.W.= ... ,Solution: Clear (2% in DMF) ,Biological ... and M13 ,Elemental Analysis: Agrees with ...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
Provides continuous mixing action. For use with tubes, vials, and other containers...
Biology Products: